FDA & EMA viewpoints: regulating adjuvanted #influenza #vaccines

Dr Pieter Neels, Member Committee for Medicinal Products for Human Use at the European Medicines Agency spoke at last year's World Influenza Congress in Vienna on the reasoning behind regulatory standpoints in Europe.   And he did address the elephant in the room before getting started, saying that:   "Regulators cannot do any good: If we are critical: we are …